samedan logo
home > ebr > spring 2020 > transforming cell and gene therapy trial design and execution


Dear guest!

article: Transforming Cell and Gene Therapy Trial Design and Execution
format: Adobe Acrobat PDF file
cost: £


News and Press Releases

Owen Mumford Launches New 2-Step Single-Use Auto-Injector Platform AidaptusŪ

OXFORD, England, 22nd September - Owen Mumford Pharmaceutical Services, a division of Owen Mumford Ltd. has launched its new AidaptusŪ auto-injector platform following successful completion of development. Aidaptus is a 2-step, spring-powered, single use auto-injector with a versatile design that accommodates both 1mL and 2.25 mL prefilled glass syringes in the same base device. It also features stopper sensing technology with a self-adjusting plunger that automatically adapts to the individual stopper positions and different fill volumes in each syringe, with no change parts required. The auto-injector is available with two different spring strengths to accommodate a variety of drug viscosities.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement